Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Goodwill & Intangibles (2020 - 2025)

Oncology Institute's Goodwill & Intangibles history spans 6 years, with the latest figure at $18.2 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 17.22% year-over-year to $18.2 million; the TTM value through Dec 2025 reached $18.2 million, down 17.22%, while the annual FY2025 figure was $18.2 million, 17.22% down from the prior year.
  • Goodwill & Intangibles reached $18.2 million in Q4 2025 per TOI's latest filing, down from $19.0 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $53.9 million in Q2 2022 to a low of $18.2 million in Q4 2025.
  • Average Goodwill & Intangibles over 5 years is $29.5 million, with a median of $24.4 million recorded in 2024.
  • Peak YoY movement for Goodwill & Intangibles: skyrocketed 32.98% in 2021, then crashed 50.72% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $44.9 million in 2021, then fell by 12.25% to $39.4 million in 2022, then crashed by 36.17% to $25.1 million in 2023, then fell by 12.31% to $22.0 million in 2024, then decreased by 17.22% to $18.2 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Goodwill & Intangibles are $18.2 million (Q4 2025), $19.0 million (Q3 2025), and $19.7 million (Q2 2025).